Cédric Dos Santos

2.3k total citations
36 papers, 1.5k citations indexed

About

Cédric Dos Santos is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Cédric Dos Santos has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 14 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Cédric Dos Santos's work include Acute Myeloid Leukemia Research (17 papers), Multiple Myeloma Research and Treatments (8 papers) and Immune Cell Function and Interaction (7 papers). Cédric Dos Santos is often cited by papers focused on Acute Myeloid Leukemia Research (17 papers), Multiple Myeloma Research and Treatments (8 papers) and Immune Cell Function and Interaction (7 papers). Cédric Dos Santos collaborates with scholars based in United States, France and China. Cédric Dos Santos's co-authors include Bernard Payrastre, Christian Récher, Cécile Demur, Ravi Bhatia, Stephen J. Forman, Tinisha McDonald, Guy Laurent, Véronique Mansat‐De Mas, Odile Beyne‐Rauzy and Françoise Huguet and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Cédric Dos Santos

35 papers receiving 1.5k citations

Peers

Countries citing papers authored by Cédric Dos Santos

Since Specialization

Citations

This map shows the geographic impact of Cédric Dos Santos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cédric Dos Santos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cédric Dos Santos more than expected).

Fields of papers citing papers by Cédric Dos Santos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cédric Dos Santos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cédric Dos Santos. The network helps show where Cédric Dos Santos may publish in the future.

Co-authorship network of co-authors of Cédric Dos Santos

This figure shows the co-authorship network connecting the top 25 collaborators of Cédric Dos Santos. A scholar is included among the top collaborators of Cédric Dos Santos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cédric Dos Santos. Cédric Dos Santos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protein Coaggregation in Caribbean Atypical Parkinsonism: The Contribution of Annonacin 2025 ·Neuropathology and Applied Neurobiology ·Florencia González‐Lizárraga, Susana Boluda, José Ruiz Hidalgo, César L. Ávila, Cédric Dos Santos, (unknown), (unknown), (unknown), (unknown), Emmanuel Roze, Rosana Chehı́n, Rita Raisman‐Vozari, Patrick P. Michel, Annie Lannuzel	0
2	1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma 2024 ·Nature Communications ·Travis S. Johnson, Parvathi Sudha, (unknown), (unknown), (unknown), Patrick Blaney, Gareth J. Morgan, Vivek S. Chopra, Cédric Dos Santos, Michael Nixon, Kun Huang, Attaya Suvannasankha, Mohammad Abu Zaid, Rafat Abonour, Brian A. Walker	3
3	Stratification of Multiple Myeloma Patients in the Commpass Study By Single Cell Transcriptomics of Plasma Cells Associates with Clinical Outcome 2023 ·Blood ·(unknown), Xiangnan Guan, (unknown), Minfang Song, Wenjin Li, Cédric Dos Santos, Habib Hamidi	2
4	Immune microenvironment characteristics in multiple myeloma progression from transcriptome profiling 2022 ·Frontiers in Oncology ·Jin Wang, Yi Hu, Habib Hamidi, Cédric Dos Santos, Jingyu Zhang, Elizabeth A. Punnoose, Wenjin Li	8
5	A phase 1b study of blinatumomab in Japanese children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia 2020 ·International Journal of Hematology ·Keizo Horibe, Joan Morris, Catherine Tuglus, Cédric Dos Santos, James Kalabus, Abraham Anderson, Hiroaki Goto, Chitose Ogawa	9
6	Clinical Outcomes in Patients with FLT3-ITD-Mutated Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Quizartinib or Salvage Chemotherapy in the QuANTUM-R Trial 2020 ·Transplantation and Cellular Therapy ·Siddhartha Ganguly, Jörge E. Cortes, Alwin Krämer, Mark J. Levis, Giovanni Martinelli, Alexander E. Perl, Nigel H. Russell, Meena Arunachalam, Cédric Dos Santos, Guy Gammon, Arnaud Lesegretain, (unknown), (unknown), Yibin Wang, Samer K. Khaled	22
7	A quantitative method for detection of circulating fms related tyrosine kinase 3 (FLT-3) in acute myeloid leukemia (AML) patients 2019 ·Journal of Immunological Methods ·Kevin D. Cook, Elizabeth Finger, Cédric Dos Santos, Dan A. Rock	1
8	CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells 2018 ·Journal for ImmunoTherapy of Cancer ·Regina Jitschin, Domenica Saul, Martina Braun, (unknown), Simon Völkl, Roman Kischel, Michael Lutteropp, Cédric Dos Santos, Andréas Mackensen, Dimitrios Mougiakakos	72
9	Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cells 2018 ·Haematologica ·Maria Krevvata, Xiaochuan Shan, (unknown), Cédric Dos Santos, (unknown), Anthony Secreto, Joshua Glover, Winifred Trotman, (unknown), Selene Nuñez-Cruz, Gerald Wertheim, Hyun-Jeong Ra, Elizabeth A. Griffiths, (unknown), Gwenn Danet-Desnoyers, Martin Carroll	28
10	Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option 2018 ·Oncogene ·Hauke Stamm, (unknown), (unknown), Jana Muschhammer, Eik Vettorazzi, Michael Heuser, Ulrike Mock, Felicitas Thol, Gabi Vohwinkel, (unknown), Carsten Bokemeyer, Roman Kischel, Cédric Dos Santos, Sabine Stienen, Matthias Friedrich, Michael Lutteropp, Dirk Nagorsen, Jasmin Wellbrock, Walter Fiedler	82
11	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220 2017 ·Cancer Research ·Panpan Hou, Chao Wu, Yuchen Wang, Rui Qi, Dheeraj Bhavanasi, Zhixiang Zuo, Cédric Dos Santos, Shuliang Chen, Yu Chen, Hong Zheng, Hong Wang, Alexander E. Perl, Deyin Guo, Jian Huang	68
12	Treatment of Acute Myeloid Leukemia in Elderly Patients—A Therapeutic Dilemma 2016 ·Journal of the American Medical Directors Association ·Hirva Mamdani, Cédric Dos Santos, Helmut König	9
13	Signal transduction in Acute Myeloid Leukemia – Implications for Novel Therapeutic Concepts. 2015 ·Current Cancer Drug Targets ·Helmut König, Cédric Dos Santos	4
14	Anti-Leukemic Activity of Daratumumab in Acute Myeloid Leukemia Cells and Patient-Derived Xenografts 2014 ·Blood ·Cédric Dos Santos, Xiaochuan Shan, Chenghui Zhou, (unknown), Joshua Glover, (unknown), Parul Doshi, Kate Sasser, Gwenn Danet-Desnoyers	12
15	The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents 2013 ·Blood ·Cédric Dos Santos, Tinisha McDonald, Yin Wei Ho, Hongjun Liu, Allen Lin, Stephen J. Forman, Ya‐Huei Kuo, Ravi Bhatia	79
16	T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia 2013 ·Blood ·Armen Mardiros, Cédric Dos Santos, Tinisha McDonald, Christine E. Brown, Xiuli Wang, Lihua E. Budde, Lauren Hoffman, Brenda Aguilar, Wen-Chung Chang, (unknown), Brenda Chang, Mahesh Jonnalagadda, Renate Starr, Julie R. Ostberg, Michael C. Jensen, Ravi Bhatia, Stephen J. Forman	300
17	A functional link between Polo-like kinase 1 and the mammalian Target-Of-Rapamycin pathway? 2010 ·Cell Cycle ·(unknown), Laurent Créancier, Cédric Dos Santos, (unknown), (unknown), Christian Bailly, Anna Kruczynski, Bernard Payrastre, Stéphane Manenti	21
18	The level of AKT phosphorylation on threonine 308 but not on serine 473 is associated with high-risk cytogenetics and predicts poor overall survival in acute myeloid leukaemia 2009 ·Leukemia ·Nathalie Gallay, Cédric Dos Santos, Lise Cuzin, Marina Bousquet, (unknown), Claire Chaussade, Michel Attal, Bernard Payrastre, Cécile Demur, Christian Récher	103
19	La voie PI3K/Akt/mTOR : une nouvelle cible thérapeutique dans le traitement des leucémies aiguës myéloïdes 2006 ·Bulletin du Cancer ·Cédric Dos Santos, Christian Récher, Cécile Demur, Bernard Payrastre	11
20	Uncoupling between Immunological Synapse Formation and Functional Outcome in Human γδ T Lymphocytes 2003 ·The Journal of Immunology ·Benoı̂t Favier, Éric Espinosa, Julie Tabiasco, Cédric Dos Santos, Marc Bonneville, Salvatore Valitutti, Jean‐Jacques Fournié	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact